外周血C-X-C基序趋化因子配体9和C-C基序趋化因子配体20与脓毒症合并心肌损伤患者心肌损伤指标及预后的关系

Relationships of C-X-C motif chemokine ligand 9 and C-C motif chemokine ligand 20 in peripheral blood with myocardial injury indicators and prognosis in sepsis patients complicated by myocardial injury

  • 摘要:
    目的 探讨外周血C-X-C基序趋化因子配体9(CXCL9)、C-C基序趋化因子配体20(CCL20)与脓毒症合并心肌损伤(SIMD)患者心肌损伤指标及预后的关系。
    方法 前瞻性选取2022年1月—2024年10月本院收治的116例SIMD患者(SIMD组)和116例单纯脓毒症患者(非SIMD组)为研究对象,并根据28 d预后结局将SIMD患者分为死亡组与存活组。检测患者外周血CXCL9、CCL20和心肌损伤指标心肌肌钙蛋白I(cTnI)、肌酸激酶同工酶MB(CK-MB)、N末端前体脑利钠肽(NT-proBNP)水平。采用斯皮尔曼相关性分析探讨SIMD患者外周血CXCL9、CCL20与cTnI、CK-MB、NT-proBNP的相关性,分析外周血CXCL9、CCL20与SIMD患者预后的关系。
    结果 与非SIMD组比较, SIMD组外周血CXCL9、CCL20、cTnI、CK-MB、NT-proBNP水平升高,差异有统计学意义(P<0.05)。斯皮尔曼相关性分析显示, SIMD患者外周血CXCL9、CCL20与cTnI、CK-MB、NT-proBNP水平均呈正相关(rs=0.798、0.697、0.629、0.763、0.631、0.613, 均P<0.001)。116例SIMD患者28 d死亡率为43.97%(51/116)。与存活组比较,死亡组急性生理学与慢性健康状况评分系统Ⅱ(APACHEⅡ)评分、序贯器官衰竭评估(SOFA)评分增加, cTnI、CK-MB、NT-proBNP、CXCL9、CCL20水平升高,差异有统计学意义(P<0.001)。Logistic回归分析显示, APACHEⅡ评分高、SOFA评分高、cTnI水平高、NT-proBNP水平高、CXCL9水平高、CCL20水平高是SIMD患者死亡的独立危险因素(P<0.05)。受试者工作特征(ROC)曲线分析显示,外周血cTnI、NT-proBNP、CXCL9、CCL20联合预测SIMD患者死亡的曲线下面积(AUC)为0.953, 大于外周血cTnI、NT-proBNP、CXCL9、CCL20单独预测的0.750、0.734、0.813、0.816(Z=4.584、4.832、3.995、4.107, 均P<0.001); 经1 000次Bootstrap法自抽样内部验证, 4项指标联合预测的一致性指数为0.953(95%CI: 0.946~0.959)。
    结论 外周血CXCL9、CCL20水平升高与SIMD患者心肌损伤加重和预后不良有关,二者联合预测预后的效能更高。

     

    Abstract:
    Objective To investigate the relationships of C-X-C motif chemokine ligand 9 (CXCL9) and C-C motif chemokine ligand 20 (CCL20) in the peripheral blood with myocardial injury indicators as well as prognosis in patients with sepsis-induced myocardial injury (SIMD).
    Methods A total of 116 SIMD patients (SIMD group) and 116 patients with sepsis alone (non-SIMD group) in the hospital from January 2022 to October 2024 were prospectively selected as the research objects. The SIMD patients were further divided into death group and survival group according to their 28-day prognostic outcomes. The levels of CXCL9 and CCL20 in the peripheral blood and myocardial injury indicatorscardiac troponin I (cTnI), creatine kinase isoenzyme MB (CK-MB), and N-terminal pro-brain natriuretic peptide (NT-proBNP) were measured in these patients. Spearman correlation analysis was used to explore the correlations of CXCL9 and CCL20 in the peripheral blood with cTnI, CK-MB and NT-proBNP in SIMD patients, and the relationships of CXCL9 and CCL20 in the peripheral blood with the prognosis of SIMD patients were analyzed.
    Results Compared with the non-SIMD group, the levels of CXCL9 and CCL20 in the peripheral blood, cTnI, CK-MB, and NT-proBNP in the SIMD group were significantly elevated (P < 0.05). Spearman correlation analysis showed that CXCL9 and CCL20 in the peripheral blood in SIMD patients were positively correlated with the levels of cTnI, CK-MB and NT-proBNP (rs=0.798, 0.697, 0.629, 0.763, 0.631, 0.613, all P < 0.001). Among the 116 SIMD patients, the 28-day mortality rate was 43.97% (51/116). Compared with the survival group, the death group had significantly higher scores on the Acute Physiology and Chronic Health Evaluation Ⅱ (APACHE Ⅱ) and Sequential Organ Failure Assessment (SOFA), as well as significantly elevated levels of cTnI, CK-MB, NT-proBNP, CXCL9 and CCL20 (P < 0.001). Logistic regression analysis revealed that high APACHE Ⅱ score, high SOFA score, high cTnI level, high NT-proBNP level, high CXCL9 level, and high CCL20 level were independent risk factors for death in SIMD patients (P < 0.05). Receiver operating characteristic (ROC) curve analysis demonstrated that the area under the curve (AUC) for the combined prediction of death in SIMD patients by cTnI, NT-proBNP, CXCL9 and CCL20 was 0.953, which was greater than 0.750, 0.734, 0.813 and 0.816 for the individual prediction by cTnI, NT-proBNP, CXCL9 and CCL20 (Z=4.584, 4.832, 3.995 and 4.107, all P < 0.001). After 1, 000-time Bootstrap self-sampling internal validation, the concordance index for the combined prediction by the four indicators was 0.953 (95%CI, 0.946 to 0.959).
    Conclusion Elevated levels of CXCL9 and CCL20 in the peripheral blood are associated with aggravated myocardial injury and poor prognosis in SIMD patients, and the combined prediction of prognosis by two markers has higher efficacy.

     

/

返回文章
返回